Differentiation and hematopoietic-support of clonal cells in myelodysplastic syndromes

References

• Valent P, Wimazal F, Schwarzinger I, Sperr W R, Geissler K. Pathogenesis, classification, and treatment of myelodysplastic syndromes (MDS). Wien Klin Wochenschr 2003; 115: 515–536
   PubMed Web of Science ®Google Scholar
• Marisavljevic D, Rolovic Z, Ludoski-Pantic M, Djordjevic V, Novak A. Spontaneous remission in adults with primary myelodysplastic syndromes: incidence and characteristics of patients. Med Oncol 2005; 22: 407–410
   PubMed Web of Science ®Google Scholar
• Maywald O, Buchheidt D, Bergmann J, Schoch C, Ludwig W D, Reiter A, et al. Spontaneous remission in adult acute myeloid leukemia in association with systemic bacterial infection-case report and review of the literature. Ann Hematol 2004; 83: 189–194
   PubMed Web of Science ®Google Scholar
• Bernell P, Jacobsson B, Nordgren A, Hast R. Clonal cell lineage involvement in myelodysplastic syndromes studied by fluorescence in situ hybridization and morphology. Leukemia 1996; 10: 662–668
   PubMed Web of Science ®Google Scholar
• Krejcova H, Neuwirtova R, Cermak J, Belickova M, Brdicka R. Cell clonality in myelodysplastic syndrome. Sb Lek 2002; 103: 339–348
   PubMedGoogle Scholar
• Koeffler H P, Golde D W. Human preleukemia. Ann Int Med 1980; 93: 347–353
   PubMed Web of Science ®Google Scholar
• Saitoh K, Miura I, Takahashi N, Miura A B. Fluorescence in situ hybridization of progenitor cells obtained by fluorescence-activated cell sorting for the detection of cells affected by chromosome abnormality trisomy 8 in patients with myelodysplastic syndromes. Blood 1998; 92: 2886–2892
   PubMed Web of Science ®Google Scholar
• Cauwelier B, Nollet F, De Laere E, Van Leeuwen M, Billiet J, Criel A, Louwagie A. Simultaneous occurrence of myelodysplastic syndrome and monoclonal B lymphocytes with a different clonal origin. Leuk Lymphoma 2002; 43: 191–193
   PubMed Web of Science ®Google Scholar
• Delacretaz F, Schmidt P M, Piguet D, Bachmann F, Costa J. Histopathology of myelodysplastic syndromes. The FAB classification (proposals) applied to bone marrow biopsy. Am J Clin Pathol 1987; 87: 180–186
   PubMed Web of Science ®Google Scholar
• Multani A S, Hopwood V L, Pathak S. A modified fluorescence in situ hybridization (FISH) technique. Anticancer Res 1996; 16: 3435–3437
   PubMed Web of Science ®Google Scholar
• van Lom K, Houtsmuller A B, van Putten W L, Slater R M, Lowenberg B. Cytogenetic clonality analysis of megakaryocytes in myelodysplastic syndrome by dual-color fluorescence in situ hybridization and confocal laser scanning microscopy. Genes Chromosomes Cancer 1999; 25: 332–338
   PubMed Web of Science ®Google Scholar
• Alvarez-Larran A, Toll T, Rives S, Estella J. Assessment of neutrophil activation in whole blood by flow cytometry. Clin Lab Haematol 2005; 27: 41–46
   PubMedGoogle Scholar
• Levine R F. Isolation and characterization of normal human megakaryocytes. Br J Haematol 1980; 45: 487–497
   PubMed Web of Science ®Google Scholar
• Beris P. Primary clonal myelodysplastic syndromes. Sem Hematol 1989; 26: 216–233
   PubMed Web of Science ®Google Scholar
• Thanopoulou E, Cashman J, Kakagianne T, Eaves A, Zoumbos N, Eaves C. Engraftment of NOD/SCID-beta2 microglobulin null mice with multilineage neoplastic cells from patients with myelodysplastic syndrome. Blood 2004; 103: 4285–4293
   PubMed Web of Science ®Google Scholar
• Galton D AG. The myelodysplastic syndrome. Scan Ematol 1986; 36(suppl 45)11
   PubMed Web of Science ®Google Scholar
• Schmetzer H M, Poleck B, Duell T, Gerhartz H H, Mittermuller J. Cytogenetic and Southern blot analysis to demonstrate clonality and to estimate prognosis in patients with myelodysplastic syndromes. Ann Hematol 2000; 79: 20–29
   PubMed Web of Science ®Google Scholar
• Greenberg P, Cox C, LeBeau M M, Fenaux P, Morel P, Sanz G, et al. International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood 1997; 89: 2079–2088
   PubMed Web of Science ®Google Scholar
• Ohyashiki K, Sasao I, Ohyashiki J H, Murakami T, Tauchi T, Iwabuchi A, Toyama K. Cytogenetic and clinical findings of myelodysplastic syndromes with a poor prognosis. An experience with 97 cases. Cancer 1992; 70: 94–99
   PubMed Web of Science ®Google Scholar
• Ishikawa S, Sasaki Y, Hirota M, Okumura N, Furihata K, Tozuka M. Determination of neutrophil function by measuring superoxide production with whole blood flow cytometry. Rinsho Byori 1997; 45: 1057–1061
   PubMedGoogle Scholar
• Verhoef G, Boogaerts M. In vivo administration of granulocyte-macrophage colony stimulating factor enhances neutrophil function in patients with myelodysplastic syndromes. Br J Haematol 1991; 79: 177–184
   PubMed Web of Science ®Google Scholar
• Cantu Rajnoldi A, Fenu S, Kerndrup G, van Wering E R, Niemeyer C M, Baumann I. European Working Group on Myelodysplastic Syndromes in Childhood (EWOG-MDS). Evaluation of dysplastic features in myelodysplastic syndromes: Experience from the morphology group of the European Working Group of MDS in Childhood (EWOG-MDS). Ann Hematol 2005; 84: 429–433
   PubMed Web of Science ®Google Scholar
• Hast R, Eriksson M, Widell S, Arvidsson I, Bemell P. Neutrophil dysplasia is not a specific feature of the abnormal chromosomal clone in myelodysplastic syndromes. Leuk Res 1999; 23: 579–584
   PubMed Web of Science ®Google Scholar
• Li X, Pu Q. Megakaryocytopoiesis and apoptosis in patients with myelodysplastic syndromes. Leuk Lymphoma 2005; 46: 387–391
   PubMed Web of Science ®Google Scholar
• Li X, Bryant C E, Deeg H J. Simultaneous demonstration of clonal chromosome abnormalities and apoptosis in individual marrow cells in myelodysplastic syndrome. Int J Hematol 2004; 80: 140–145
   PubMed Web of Science ®Google Scholar
• Nilsson L, Astrand-Grundstrom I, Anderson K, Arvidsson I, Hokland P, Bryder D, et al. Involvement and functional impairment of the CD34(+)CD38(−)Thy-1(+) hematopoietic stem cell pool in myelodysplastic syndromes with trisomy 8. Blood 2002; 100: 259–267
   PubMed Web of Science ®Google Scholar
• White A D, Hoy T G, Jacobs A. Extended cytogenetic follow-up and clinical progress in patients with myelodysplastic syndromes (MDS). Leuk Lymphoma 1994; 12: 401–412
   PubMed Web of Science ®Google Scholar
• Swolin B, Rodjer S, Roupe G. Cytogenetic studies in patients with mastocytosis. Cancer Genet Cytogenet 2000; 20: 31–135
   Google Scholar
• Sloand E M, Mainwaring L, Fuhrer M, Ramkissoon S, Risitano A M, Keyvanafar K, et al. Preferential suppression of trisomy 8 compared with normal hematopoietic cell growth by autologous lymphocytes in patients with trisomy 8 myelodysplastic syndrome. Blood 2005; 106: 841–851
   PubMed Web of Science ®Google Scholar